14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $0.0060 $169.56 Friday, 27th May 2022 ANTH stock ended at $0.000001. During the day the stock fluctuated 0% from a day low at $0.000001 to a day high of $0.000001.
90 days $113.65 $133.77
52 weeks $171.20 $133.77

Historical Anthera Pharmaceuticals prices

Date Open High Low Close Volume
Feb 12, 2021 $0.0610 $0.0610 $0.0580 $0.0590 139 560
Feb 11, 2021 $0.0610 $0.0610 $0.0580 $0.0590 422 087
Feb 10, 2021 $0.0600 $0.0600 $0.0580 $0.0600 132 798
Feb 09, 2021 $0.0563 $0.0610 $0.0563 $0.0600 132 798
Feb 08, 2021 $0.0600 $0.0600 $0.0580 $0.0595 117 214
Feb 05, 2021 $0.0600 $0.0600 $0.0560 $0.0600 84 452
Feb 04, 2021 $0.0600 $0.0600 $0.0551 $0.0600 165 454
Feb 03, 2021 $0.0600 $0.0600 $0.0520 $0.0580 290 757
Feb 02, 2021 $0.0590 $0.0590 $0.0494 $0.0580 290 757
Feb 01, 2021 $0.0425 $0.0540 $0.0425 $0.0519 200 466
Jan 29, 2021 $0.0420 $0.0460 $0.0401 $0.0414 92 871
Jan 28, 2021 $0.0350 $0.0460 $0.0350 $0.0420 155 998
Jan 27, 2021 $0.0360 $0.0400 $0.0351 $0.0399 141 505
Jan 26, 2021 $0.0353 $0.0400 $0.0350 $0.0388 204 560
Jan 25, 2021 $0.0450 $0.0460 $0.0352 $0.0388 204 560
Jan 22, 2021 $0.0391 $0.0410 $0.0391 $0.0410 69 556
Jan 21, 2021 $0.0400 $0.0410 $0.0351 $0.0410 292 023
Jan 20, 2021 $0.0380 $0.0410 $0.0311 $0.0410 150 228
Jan 19, 2021 $0.0450 $0.0450 $0.0310 $0.0410 84 528
Jan 15, 2021 $0.0310 $0.0410 $0.0310 $0.0400 123 855
Jan 14, 2021 $0.0435 $0.0435 $0.0350 $0.0400 123 855
Jan 13, 2021 $0.0450 $0.0450 $0.0310 $0.0450 1 823 952
Jan 12, 2021 $0.0201 $0.0490 $0.0201 $0.0450 1 823 952
Jan 11, 2021 $0.0213 $0.0279 $0.0202 $0.0241 92 776
Jan 08, 2021 $0.0240 $0.0240 $0.0201 $0.0233 127 929
Click to get the best stock tips daily for free!

About Anthera Pharmaceuticals

Anthera Pharmaceuticals Anthera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of medicines for patients with unmet medical needs. It develops Sollpura, a non-porcine investigational pancreatic enzyme replacement therapy that is in Phase III clinical trial for the treatment of patients with exocrine pancreatic insufficiency; and Blisibimod, which is in Phase II clinical trial for the treatment of B-cell mediated auto... ANTH Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT